This Cancer Drug Is So Effective, The FDA Approved It Immediately
June 11, 2017
A new cancer drug has overwhelmingly helped shrink or eradicate tumors in patients whose cancer had resisted every other form of treatment.
The results, published in the journal Science, are so striking that the Food and Drug Administration already has approved the drug.
Image credit: Merck
The study followed 86 cancer patients with tumors of the pancreas, prostate, uterus or bone. Each patient was given pembrolizumab, which also goes by the brand name Keytruda.
After taking the drug, 66 patients had their tumors shrink substantially and stabilize, instead of continuing to grow. Among them were 18 patients whose tumors vanished and have not returned.
According to the New York Times, this is the first time a drug has been approved for use against tumors that share a particular genetic profile, regardless of where they appear in the body.
Dr. Jack Jacoub, a medical oncologist and director of thoracic oncology at Memorial Care Cancer Institute at Orange Coast Memorial Medical Center, said "The FDA doesn't take these kinds of things lightly. The data was so good, they had to approve it."
Click Here For The Most Popular On Sunny Skyz
A Husky Was Lost. Owners Found Him With A Drone - Hanging Out With Bears
Dog Completely Changes From Black To White
Cat's Face Shows Opposite Of Gratitude After Being Rescued
A First Birthday Reunion Party For The Whole Litter, Mama Pup Included
This Senior Dog Sanctuary Celebrated 12 Years With A Dog Prom
Local Police Department Makes Public Statement To Community On Taylor Swift's New Album
Man And Dog Left Stunned After Cat FLIES Across The Room
The Cat Chooses You: A Boy's Heartwarming Shelter Adoption Story
'Thing Kept Attacking Me': Squirrel Defends Man's Home From Burglar
Dog's Hilarious Windshield Wiper Chase Captured By Motorist
Owner Purrfectly Captures Cat's Two Opposite Personalities In Viral Video